Index Fund Advisors, Inc. Caladrius Biosciences, Inc. Transaction History

Index Fund Advisors, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 25, 2022	SELL	$0.63 - $1.03 $6,573 - $10,747	-10,434 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$0.83 - $1.22 $8,660 - $12,729	10,434 New	10,434 $9,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Index Fund Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Index Fund Advisors, Inc. with notifications on news.